Pei Liang1, Susanne M Henning1, Shiruyeh Schokrpur2, Lily Wu2, Ngan Doan3, Jonathan Said3, Tristan Grogan4, David Elashoff4, Pinchas Cohen5, William J Aronson1,6. 1. Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. 2. Departments of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. 3. Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. 4. Statistics Core, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. 5. Leonard Davis School of Gerontology, University of Southern California, Los Angeles, California. 6. VA Medical Center Greater Los Angeles Healthcare System, Los Angeles, California.
Abstract
BACKGROUND: Preclinical and clinical studies suggest that a fish oil-based diet may play a role in delaying the progression of prostate cancer through a number of different mechanisms involving inflammatory pathways. Given the importance of tumor-associated macrophages (TAMs) in carcinogenesis, we hypothesized that a fish oil-based diet will inhibit TAM infiltration and delay the growth of prostate cancer. METHODS: Androgen sensitive mouse prostate cancer (MycCaP) allograft tumors were grown in fully immunocompetent FVB mice fed a high- fat fish oil (omega-3) or corn oil (omega-6) diet. Gene expression of markers for immune cell populations, cytokines, chemokines, and signaling pathways were determined by real-time PCR and western blot in tumor tissue. Cell proliferation and apoptosis in vitro were measured by MTS assay and flow cytometry. RESULTS: Tumor volumes were significantly smaller in mice in ω-3 versus the ω-6 group (P = 0.048). Gene expression of markers for M1 and M2 macrophages (F4/80, iNOS, ARG1), associated cytokines (IL-6, TNF alpha, IL-10), and the chemokine CCL-2 were also lower in the omega-3 group. Correlative in vitro studies were performed in M1 and M2 polarized macrophages and mirrored the in vivo findings. Dietary fish oil and in vitro omega-3 fatty acid administration reduced protein expression of transcription factors in the nuclear factor kappa B pathway leading to a significant decrease in gene expression of downstream targets (Bcl-2, BCL-XL, XIAP, survivin) in MycCap cells. CONCLUSIONS: These findings underscore the potential of fish oil in modulating the clinical course of human prostate cancer through the immune system. Further preclinical and clinical studies are warranted evaluating fish oil-based therapies for inhibiting the recruitment and function of M1 and M2 tumor infiltrating macrophages. Prostate 76:1293-1302, 2016.
BACKGROUND: Preclinical and clinical studies suggest that a fish oil-based diet may play a role in delaying the progression of prostate cancer through a number of different mechanisms involving inflammatory pathways. Given the importance of tumor-associated macrophages (TAMs) in carcinogenesis, we hypothesized that a fish oil-based diet will inhibit TAM infiltration and delay the growth of prostate cancer. METHODS: Androgen sensitive mouseprostate cancer (MycCaP) allograft tumors were grown in fully immunocompetent FVB mice fed a high- fat fish oil (omega-3) or corn oil (omega-6) diet. Gene expression of markers for immune cell populations, cytokines, chemokines, and signaling pathways were determined by real-time PCR and western blot in tumor tissue. Cell proliferation and apoptosis in vitro were measured by MTS assay and flow cytometry. RESULTS:Tumor volumes were significantly smaller in mice in ω-3 versus the ω-6 group (P = 0.048). Gene expression of markers for M1 and M2 macrophages (F4/80, iNOS, ARG1), associated cytokines (IL-6, TNF alpha, IL-10), and the chemokine CCL-2 were also lower in the omega-3 group. Correlative in vitro studies were performed in M1 and M2 polarized macrophages and mirrored the in vivo findings. Dietary fish oil and in vitro omega-3 fatty acid administration reduced protein expression of transcription factors in the nuclear factor kappa B pathway leading to a significant decrease in gene expression of downstream targets (Bcl-2, BCL-XL, XIAP, survivin) in MycCap cells. CONCLUSIONS: These findings underscore the potential of fish oil in modulating the clinical course of humanprostate cancer through the immune system. Further preclinical and clinical studies are warranted evaluating fish oil-based therapies for inhibiting the recruitment and function of M1 and M2 tumor infiltrating macrophages. Prostate 76:1293-1302, 2016.
Authors: Yingduan Cheng; Hua Geng; Suk Hang Cheng; Pei Liang; Yan Bai; Jisheng Li; Gopesh Srivastava; Margaret H L Ng; Tatsuo Fukagawa; Xiushan Wu; Anthony T C Chan; Qian Tao Journal: Cancer Res Date: 2010-08-03 Impact factor: 12.701
Authors: Pei Liang; Suk Hang Cheng; Chi Keung Cheng; Kin Mang Lau; Shek Ying Lin; Eudora Y D Chow; Natalie P H Chan; Rosalina K L Ip; Raymond S M Wong; Margaret H L Ng Journal: Haematologica Date: 2012-08-28 Impact factor: 9.941
Authors: Colette Galet; Kiran Gollapudi; Sevan Stepanian; Joshua B Byrd; Susanne M Henning; Tristan Grogan; David Elashoff; David Heber; Jonathan Said; Pinchas Cohen; William J Aronson Journal: Cancer Prev Res (Phila) Date: 2013-10-29
Authors: June M Chan; Vivian Weinberg; Mark J Magbanua; Eduardo Sosa; Jeffry Simko; Katsuto Shinohara; Scot Federman; Mike Mattie; Millie Hughes-Fulford; Christopher Haqq; Peter R Carroll Journal: Cancer Causes Control Date: 2010-11-20 Impact factor: 2.506
Authors: M Lanciotti; L Masieri; M R Raspollini; A Minervini; A Mari; G Comito; E Giannoni; M Carini; P Chiarugi; S Serni Journal: Biomed Res Int Date: 2014-03-11 Impact factor: 3.411
Authors: Saraswoti Khadge; Geoffrey M Thiele; John Graham Sharp; Timothy R McGuire; Lynell W Klassen; Paul N Black; Concetta C DiRusso; Leah Cook; James E Talmadge Journal: Clin Exp Metastasis Date: 2018-10-16 Impact factor: 5.150
Authors: Pei Liang; Susanne M Henning; Johnny Guan; Tristan Grogan; David Elashoff; Jerrold M Olefsky; Pinchas Cohen; William J Aronson Journal: J Natl Cancer Inst Date: 2019-01-01 Impact factor: 13.506
Authors: Magdalena Ogłuszka; Agnieszka Szostak; Marinus F W Te Pas; Ewa Poławska; Paweł Urbański; Tadeusz Blicharski; Chandra S Pareek; Edyta Juszczuk-Kubiak; Jenelle R Dunkelberger; Jarosław O Horbańczuk; Mariusz Pierzchała Journal: Genes Nutr Date: 2017-01-31 Impact factor: 5.523